Ruslan Abdullayev

Ruslan Abdullayev

Auto-generated profile, based on publicly available information

Ruslan Abdullayev

Department of Anesthesiology and Reanimation, Marmara University School of Medicine, İstanbul, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2019 in Cureus
Verified
Journal Article
Open access
PDF file
RARuslan Abdullayev
Ruslan Abdullayev
EYErcan Yildirim
Ercan Yildirim
BCBulent Celik
Bulent Celik
LSLeyla Topcu Sarica
Leyla Topcu Sarica
Analgesia nociception index (ANI) has been developed for real-time pain measurement during a surgical procedure under general anesthesia. The index is based on heart rate variability and constitutes a measure of parasympathetic tone. In this paper, we hypothesized that this index could be used as a tool to investigate the process of emotional regulation of a human subject. Twenty adult volunteers were recruited for the study, wherein ANI response to the emotional stimulus was evaluated. An emotional stimulus was obtained through a 60-second music sound record from the song “Ala Gözlerini Sevdiğim Dilber,” performed by the Turkish rock band Badem. ANI measurements were obtained before the song presentation (Tpre), at the end of the record presentation (T0), and each minute thereafter until the end of the five-minute observation (T1-T5). Twenty participants were investigated; 10 males and 10 females. The mean age of the participants was 17.0 ± 0.9 (min: 16, max: 20). ANI measurements were significantly lower in T0 and T3 compared with Tpre (P = 0.009). The differences between other values were not statistically significant. ANI can be used for assessment of parasympathetic changes related to the emotional state of conscious patients.

11 March 2022 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
RARuslan Abdullayev
Ruslan Abdullayev
FGFethi Gul
Fethi Gul
BBBeliz Bilgili
Beliz Bilgili
SSSeda Seven
Seda Seven
ICIsmail Cinel
Ismail Cinel
Aim: New coronavirus disease (COVID-19) has become an international emergency. As many of the intensive care unit (ICU) patients with the disease also present multiple organ failure, blood purification techniques might be a good choice in their treatment. In this study we aimed to investigate the role of cytokine removal in COVID-19 patients managed in ICUs. Methods: For this case-control study we have investigated the role of the cytokine removal by means of two resin membranes (HA330 and Mediasorb) in COVID-19 patients managed in ICUs. Particularly, we investigated the overtime variation in clinical severity scores, laboratory variables, and effects on hospital and ICU stay and mortality. Results: Seventy-two patients have been evaluated, of which half constituted Cytokine Filtration (CF) Group, and other half the Case-Control (CC) Group. Mortality was 55.6% and 50% in CF and CC groups, respectively. In the CF Group, there was decrease in C-reactive protein (CRP) and fibrinogen levels measured at the end of cytokine adsorption; lymphocyte count and ratio were increased, whereas neutrophile ratio was decreased. There were no differences between the groups regarding other laboratory variables, SOFA scores and vasopressor uses. Conclusions: We have demonstrated decrease in CRP, fibrinogen and increase in lymphocyte count in the patients having cytokine adsorption, but there was no clinical reflection of these benefits, and no decrease in mortality as well. Even though there is physio-pathologic rationale to use cytokine adsorption techniques for immunomodulation in critically ill COVID-19 patients, it is early to make strong suggestions about their benefits.

1 March 2017 in Brazilian Journal of Anesthesiology (English Edition)
Verified
Journal Article
Open access
ÖKÖmer Burak Küçükebe
Ömer Burak Küçükebe
DÖDeniz Özzeybek
Deniz Özzeybek
RARuslan Abdullayev
Ruslan Abdullayev
AUAdil Ustaoğlu
Adil Ustaoğlu
ITIşıl Tekmen
Işıl Tekmen
TKTuncay Küme
Tuncay Küme
PurposeIschemia–reperfusion injury is one of the consequences of tourniquet application for extremity surgery. The aim of the study was to establish the effect of dexmedetomidine on the acute lung injury following lower extremity experimental ischemia–reperfusion model in rats.MethodsTwenty-eight Wistar-Albino breed Rats were recruited after Ethics Committee approval and divided into 4 groups, each with 7 subjects. Group 1 (SHAM) received only anesthesia. Group 2 (IR) had experienced 3h of ischemia and 3h of reperfusion using left lower extremity tourniquet after anesthesia application. Groups 3 (D-50) and 4 (D-100) had undergone the same procedures as in the Group 2, except for receiving 50 and 100μg/kg, respectively, dexmedetomidine intraperitoneally 1h before the tourniquet release. Blood samples were obtained for the analysis of tumor necrosing factor-α and interleukin-6. Pulmonary tissue samples were obtained for histological analysis.Resultsno significant difference regarding blood tumor necrosing factor-α and interleukin-6 values was found among the groups, whereas pulmonary tissue injury scores revealed significant difference. Histological scores obtained from the Group 2 were significantly higher from those in the Groups 1, 3 and 4 with p-values 0.001 for each comparison. Moreover, Group 1 scores were found to be significantly lower than those in the Groups 3 and 4 with p-values 0.001 and 0.011, respectively. No significant difference was observed between the Groups 3 and 4.Conclusiondexmedetomidine is effective in reduction of the experimental ischemia–reperfusion induced pulmonary tissue injury in rats, formed by extremity tourniquet application

1 November 2016 in Revista Brasileira de Anestesiologia
Verified
Journal Article
Open access
RARuslan Abdullayev
Ruslan Abdullayev
FSFiliz Cosku Saral
Filiz Cosku Saral
OKOmer Burak Kucukebe
Omer Burak Kucukebe
HSHakan Sezgin Sayiner
Hakan Sezgin Sayiner
CBCem Bayraktar
Cem Bayraktar
SASadik Akgun
Sadik Akgun
Many conditions such as bacterial and viral infectious diseases, mechanical obstruction due to air and calculi and drugs can cause parotitis. We present a case of unusual bilateral parotitis in a patient under non-invasive continuous positive airway pressure (CPAP) therapy for chronic obstructive pulmonary disease exacerbation in intensive care unit. A 36-year-old patient was admitted to intensive care unit with the diagnosis of chronic obstructive pulmonary disease exacerbation. Antibiotherapy, bronchodilator therapy and non-invasive positive pressure ventilation were applied as treatment regimen. Painless swellings developed on the 3rd day of admission on the right and a day after this on the left parotid glands. Amylase levels were increased and ultrasonographic evaluation revealed bilateral parotitis. No intervention was made and the therapy was continued. The patient was discharged on the 6th day with clinical improvement and regression of parotid swellings without any complications. Parotitis may have occurred after retrograde air flow in the Stensen duct during CPAP application. After the exclusion of possible viral and bacteriological etiologies and possible drug reactions we can focus on this diagnosis.

1 March 2017 in Revista Brasileira de Anestesiologia
Verified
Journal Article
Open access
ÖKÖmer Burak Küçükebe
Ömer Burak Küçükebe
DÖDeniz Özzeybek
Deniz Özzeybek
RARuslan Abdullayev
Ruslan Abdullayev
AUAdil Ustaoğlu
Adil Ustaoğlu
ITIşıl Tekmen
Işıl Tekmen
TKTuncay Küme
Tuncay Küme
Dexmedetomidine is effective in reduction of the experimental ischemia-reperfusion induced pulmonary tissue injury in rats, formed by extremity tourniquet application.

7 March 2022 in Journal of Clinical Monitoring and Computing
Verified
Journal Article
Closed access
PDF file
ASAyten Saracoglu
Ayten Saracoglu
RARuslan Abdullayev
Ruslan Abdullayev
MSMustafa Sakar
Mustafa Sakar
BSBulent Sacak
Bulent Sacak
FIFeyza Girgin Incekoy
Feyza Girgin Incekoy
ZAZuhal Aykac
Zuhal Aykac